154 related articles for article (PubMed ID: 8252482)
21. Ploidy level and short-time prognosis of early cervix cancer.
Jakobsen A
Radiother Oncol; 1984 Jan; 1(3):271-5. PubMed ID: 6505263
[TBL] [Abstract][Full Text] [Related]
22. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
Martin G; Halwani F; Shibata H; Meterissian S
Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
[TBL] [Abstract][Full Text] [Related]
23. No prognostic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: a prospective study of 465 patients.
Kristensen GB; Kaern J; Abeler VM; Hagmar B; Tropé CG; Pettersen EO
Gynecol Oncol; 1995 Apr; 57(1):79-85. PubMed ID: 7705705
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of prognostic factors following flow-cytometric DNA analysis after cytokeratin labelling: II. Cervical and endometrial cancer.
Wimberger P; Hillemanns P; Kapsner T; Hepp H; Kimmig R
Anal Cell Pathol; 2002; 24(4-5):147-58. PubMed ID: 12590151
[TBL] [Abstract][Full Text] [Related]
25. The prognostic value of a histologic grading system, DNA profile, and MIB-1 expression in early stages of cervical squamous cell carcinomas.
Graflund M; Sorbe B; Bryne M; Karlsson M
Int J Gynecol Cancer; 2002; 12(2):149-57. PubMed ID: 11975674
[TBL] [Abstract][Full Text] [Related]
26. DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.
Coleman RL; Schink JC; Miller DS; Bauer KD; August CZ; Rademaker AW; Lurain JR
Gynecol Oncol; 1993 Jul; 50(1):20-4. PubMed ID: 8349159
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
28. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
[TBL] [Abstract][Full Text] [Related]
29. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
[TBL] [Abstract][Full Text] [Related]
31. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
Haffty BG; Toth M; Flynn S; Fischer D; Carter D
J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.
Werner-Wasik M; Schmid CH; Bornstein L; Ball HG; Smith DM; Madoc-Jones H
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1309-17. PubMed ID: 7635770
[TBL] [Abstract][Full Text] [Related]
34. Survival and prognostic factors comparing stage IB 1 versus stage IB 2 cervical cancer treated with primary radical hysterectomy.
Srisomboon J; Kietpeerakool C; Suprasert P; Manopanya M; Siriaree S; Charoenkwan K; Cheewakriangkrai C; Sae-Teng C
Asian Pac J Cancer Prev; 2011; 12(7):1753-6. PubMed ID: 22126559
[TBL] [Abstract][Full Text] [Related]
35. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
[TBL] [Abstract][Full Text] [Related]
36. Flow cytometric analysis of DNA ploidy, percent S-phase fraction, and total proliferative fraction as prognostic indicators of local control and survival following radiation therapy for prostate carcinoma.
Centeno BA; Zietman AL; Shipley WU; Sobczak ML; Shipley JW; Preffer FI; Boyle BJ; Colvin RB
Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):309-15. PubMed ID: 7928459
[TBL] [Abstract][Full Text] [Related]
37. Deoxyribonucleic acid flow cytometric analysis of cervical adenocarcinoma: prognostic significance of deoxyribonucleic acid ploidy and S-phase fraction.
Leminen A; Paavonen J; Vesterinen E; Forss M; Wahlström T; Kulomaa P; Lehtinen M
Am J Obstet Gynecol; 1990 Mar; 162(3):848-53. PubMed ID: 2316596
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in stage IB-IIB cervical adenocarcinoma patients treated with radical hysterectomy and pelvic lymphadenectomy.
Kodama J; Seki N; Masahiro S; Kusumoto T; Nakamura K; Hongo A; Hiramatsu Y
J Surg Oncol; 2010 Apr; 101(5):413-7. PubMed ID: 20127891
[TBL] [Abstract][Full Text] [Related]
39. Flow cytometric DNA content analysis of paraffin-embedded tissue derived from cervical carcinoma.
Konski A; Domenico D; Irving D; Tyrkus M; Neisler J; Phibbs G; Bishop K; Mah J; Eggleston W
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):839-43. PubMed ID: 7960985
[TBL] [Abstract][Full Text] [Related]
40. Flow cytometric analysis of primary cervical and vulvar carcinomas and their metastases.
Siracký J; Kysela B; Siracká E
Neoplasma; 1989; 36(4):437-45. PubMed ID: 2770930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
